Bradley J Erickson Selected Research

Mitogen-Activated Protein Kinases

1/2018

Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bradley J Erickson Research Topics

Disease

11	Neoplasms (Cancer) 04/2021 - 01/2003
8	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022 - 02/2016
7	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 09/2015
4	Glioma (Gliomas) 01/2020 - 04/2006
3	Brain Neoplasms (Brain Tumor) 01/2020 - 12/2016
2	Cysts 07/2021 - 01/2018
2	Hip Dislocation 01/2021 - 01/2021
2	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 07/2011
2	Disease Progression 01/2021 - 01/2018
2	Multiple Sclerosis 01/2021 - 07/2011
1	Edema (Dropsy) 07/2021
1	Heart Failure 07/2021
1	Hypoglycemia (Reactive Hypoglycemia) 07/2021
1	Acromegaly 04/2021
1	Pituitary Neoplasms (Pituitary Adenoma) 04/2021
1	Colorectal Neoplasms (Colorectal Cancer) 04/2021
1	Growth Hormone-Secreting Pituitary Adenoma 04/2021
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Prolactinoma (Prolactinomas) 03/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2015
1	Diabetes Insipidus 05/2013
1	Neuromyelitis Optica (Devic's Disease) 07/2011
1	Neoplasm Metastasis (Metastasis) 06/2010
1	Pain (Aches) 06/2010
1	Myelitis 03/2010
1	Spinal Cord Compression 03/2010
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2003
1	Oligodendroglioma 01/2003
1	Carotid Stenosis (Carotid Artery Stenosis) 06/2002

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2015
3	Temozolomide (Temodar)FDA LinkGeneric 10/2019 - 01/2018
3	GadoliniumIBA 03/2010 - 06/2002
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020 - 01/2018
2	MethyltransferasesIBA 01/2020 - 10/2017
2	Pharmaceutical PreparationsIBA 01/2020 - 09/2015
1	Pioglitazone (Actos)FDA Link 07/2021
1	EnzymesIBA 07/2021
1	ThiazolidinedionesIBA 07/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2021
1	CAM 5.2 antigenIBA 04/2021
1	Biological ProductsIBA 04/2021
1	Growth Hormone (Somatotropin)IBA 04/2021
1	DNA Repair EnzymesIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 10/2019
1	TEMPOIBA 02/2019
1	Tolvaptan FDA Link 02/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018
1	raf KinasesIBA 01/2018
1	Contrast MediaIBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	temsirolimus FDA Link 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Arginine Vasopressin (Argipressin)IBA 01/2018
1	O-(6)-methylguanineIBA 10/2017
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 06/2016
1	Dopamine Agonists (Dopamine Agonist)IBA 03/2015
1	Dihydrotachysterol (AT 10)IBA 01/2015
1	Hormones (Hormone)IBA 05/2013
1	SteroidsIBA 07/2011
1	Immunoglobulin G (IgG)IBA 07/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2010
1	Vincristine (Oncovin)FDA LinkGeneric 01/2003
1	Procarbazine (Matulane)FDA Link 01/2003
1	Lomustine (CCNU)FDA Link 01/2003

Therapy/Procedure

8	Therapeutics 04/2021 - 01/2003
3	Radiotherapy 01/2018 - 01/2003
2	Palliative Care (Palliative Therapy) 04/2021 - 06/2010
2	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2003
1	Operative Surgical Procedures 01/2021
1	Cytoreduction Surgical Procedures 01/2020
1	Plasma Exchange 07/2011
1	Cryosurgery 06/2010
1	Surgical Decompression 03/2010